EFFECT OF HEMATOMA VOLUME ON THE 30-DAY MORTALITY RATE OF PATIENTS WITH HYPERTENSIVE INTRACEREBRAL HEMORRHAGE

Abstract

Abstract Background: Hypertensive intracerebral hemorrhage is a severe and often fatal condition, with the volume of the resulting hematoma being a critical factor influencing patient outcomes. Although few studies have been conducted previously the precise impact of hematoma volume on the short term (30-day) mortality rate remains inadequately understood and quantified. Objectives: To evaluate the effect of hematoma volume on the 30-day mortality rate of patients with hypertensive intracerebral Hemorrhage in patients who visited SPHMMC and AABET hospital from February 2023 GC-March 2024 GC Methods: A retrospective record review was done on clinical information of patients who underwent treatment for hypertensive intracerebral hemorrhage. The study covered all patients who fulfilled the inclusion and exclusion criteria. The clinical indicators and risk factors that influence 30-day mortality were evaluated using both Bivariate and multivariate logistic regression. Results: A total of 71 patients were involved in the study and 49 (69%) were alive and 22 (31%) were dead. Patients with a history of ICH are 18.67 times more likely to die within 30 days than patients who do not have a history of ICH (AOR= 18.67 95%CI=1.18-294.61). Patients who were admitted with a GCS of 3-8 are 26 times more likely to die within 30 days than patients admitted with a GCS of 9-15 (AOR=26 95%CI=1.08-63.8). Patients with hematoma volume of <30ml have an 88% lower 30-day mortality risk than patients with hematoma volume of >=60ml (AOR= 0.12 95%CI=0.01-0.85). Individuals with normal platelet counts at admission have a 94.8% lower 30 day mortality risk than those with platelet counts below normal (AOR= 0.052 95%CI=0.007 0.407). Conclusion and recommendations: This study found hematoma volume; admission Glasgow Coma Scale, admission platelet count, and prior history of intracerebral hemorrhage were identified as independent and significant predictors of 30-day mortality. Prognostication and early intervention for this patient group are advised in light of our findings. Key words: Hematoma Volume, 30-Day Mortality, Hypertensive Intracerebral Haemorrhage, Ethiopia